Revance Therapeutics, Inc.: SCHEDULE 13G/A filed Mar 6, 2025

Form type

SCHEDULE 13G/A

Filing date

Mar 6, 2025

Accession number

0000019617-25-000296

Filer

Revance Therapeutics, Inc. (CIK 1479290)